One important highlight is the observation that HDAC inhibition could improve cancer cells’ immune response via the regulation of the expressions of tumor antigens, including CD40, CD80, CD86, MHC, ICAM-1 and MICA/B, which drive the elimination of cancer cell proliferation through the immune system [283,284,285,286]. The gene discussed is CD86; the disease is cancer.